Drug Modeling Software Market Scope And Analysis

Report Code : TIPRE00013619
Category : Technology, Media and Telecommunications

No. of Pages : 150

Buy Now

Drug Modelling Software Market Analysis and Scope (2024 to 2031)

Buy Now

Drug Modelling Software Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 7.96 Billion
Market Size by 2031	US$ 17.14 Billion
Global CAGR (2023 - 2031)	10.1%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Product Type Database Software By Application Drug Discovery and Development Computational Physiological Medicine Disease Modelling Medical Imaging Predictive Analysis of Drug Targets Simulation Software Cellular Simulation
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Crown Bioscience Inc Chemical Computing Group Ulc Nimbus Therapeutics Schr dinger Inc Dassault Syst mes Genedata Ag Biognos Ab Compugen Ltd Acellera ltd Leadscope Inc

Drug Modelling Software Market News and Recent Developments

The Drug Modelling Software Market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. The following is a list of developments in the market for drug modelling software and strategies:

The company launched more than two dozen new microservices that allow healthcare enterprises worldwide to take advantage of the latest advances in generative AI from anywhere and on any cloud. The company has accelerated software development kits and tools, including Parabricks, MONAI, NeMo, Riva and Metropolis, can now be accessed as NVIDIA CUDA-X microservices to accelerate healthcare workflows for drug discovery, medical imaging and genomics analysis. (Source: NVIDIA Healthcare, Newsletter, 2024)
The company launched its Biodrug Design Accelerator, a platform to manage research processes for peptide drug discovery, which many regard as a promising frontier in the field of new drug development. (Source: Fujitsu Limited, Company Website, 2023)
The company launched its AIDDISON drug discovery software, the first software-as-a-service platform that bridges the gap between virtual molecule design and real-world manufacturability through Synthia retrosynthesis software application programing interface (API) integration. It combines generative AI, machine learning and computer-aided drug-design to speed up drug development. (Source: MilliporeSigma, Newsletter, 2023)

Drug Modelling Software Market Report Coverage and Deliverables

The “Drug Modelling Software Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Market dynamics such as drivers, restraints, and key opportunities
Key future trends
Detailed PEST/Porter’s Five Forces and SWOT analysis
Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments
Detailed company profiles